Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04022915 · ClinicalTrials.gov registry record · Phase 1
PET Fibrin Imaging of DVT and PE
A Phase 1 study, sponsored by Peter Caravan.
- Terminated
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT04022915 is a Phase 1 study that was terminated before completion, run by Peter Caravan. The registered enrollment target is 6 participants.
The verdict
NCT04022915, a Phase 1 study, was terminated before completion, sponsored by Peter Caravan.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
This study aims to investigate a novel positron emission tomography(PET)-probe for imaging of fresh intravascular blood clots in pulmonary embolism (PE) and deep venous thrombosis (DVT).
Interventions
- DRUG 64Cu-FBP8
- DIAGNOSTIC_TEST PET-CT imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2019-05-13 |
| Est. Completion | 2024-08-26 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04022915
The ClinicalTrials.gov registry entry for NCT04022915 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Peter Caravan, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 64Cu-FBP8 is the first listed.
NCT04022915 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04022915 about?
NCT04022915 is a clinical study titled "PET Fibrin Imaging of DVT and PE". This study aims to investigate a novel positron emission tomography(PET)-probe for imaging of fresh intravascular blood clots in pulmonary embolism (PE) and deep venous thrombosis (DVT).
What is the current status of trial NCT04022915?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2019-05-13. Estimated completion is 2024-08-26.
What interventions are being tested in trial NCT04022915?
The interventions under investigation include: 64Cu-FBP8 (DRUG), PET-CT imaging (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04022915?
This trial is sponsored by Peter Caravan, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.